The Global Fund's Technical Review Panel (TRP) has recommended that the Global Fund Board approve 89 Round 10 grants that, over their first two years, will cost $1.76 billion. This makes Round 10 the third largest round ever of Global Fund grants (after Rounds 8 and 9).

The TRP reviewed a combined two-year funding request of $4.38 billion, representing 150 disease components and 28 health systems strengthening (HSS) components.

GFO has no information on which specific components the TRP has recommended for Board approval. But Board members have been informed by the Secretariat of some overall data. Highlights from what Board members were told, and from GFO's analysis of that information and of comparisons with Round 9, are presented below. (For the purposes of this article, we refer to all disease and HSS components as "proposals.")

• Eighty-nine Round 10 proposals have been recommended for approval, with a total two-year cost of $1.76 billion (at current exchange rates), down from $2.21 billion in Round 9 and $3.1 billion in Round 8.
• The average Round 10 proposal recommended for approval has a two-year cost of $20 million, down from $23 million in Round 9.
• The number of proposals recommended for approved in Round 10 (89) is down slightly from the number recommended in Round 9 (96).
• Fifty percent of proposals considered by the TRP in Round 10 have been recommended for approval, almost identical to the rate in Round 9 (51%).
• Proposals for malaria were the most successful in Round 10, with 79% of submitted proposals recommended for approval, compared with 54% for TB, 43% for HSS, and only 41% for HIV. The success rate for malaria is up significantly from Round 9. See the table below for more details.

The TRP completed its review of proposals on 30 October 2010. Individual applicants should be informed shortly, if they have not already been, of what the TRP has recommended regarding their specific proposals. Then, on 13-15 December, the Board will make a final decision regarding each proposal.